14 results
PRE 14A
CCCC
C4 Therapeutics Inc
18 Apr 23
Preliminary proxy
7:59am
and skills, including his financial leadership experience within the life sciences industry.
Malcolm S. Salter has served as our director since … , qualifications, attributes and skills, including his extensive corporate leadership experience.
Vote Required
To be approved, the election of Class III
DEF 14A
987kvdv pb7
26 Apr 21
Definitive proxy
4:22pm
424B4
8og7uhy5za
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
0k5xsr7p
28 Sep 20
IPO registration (amended)
6:07am
S-1
EX-10.12
oxje9cnaoux8kld85wyu
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.11
ud5rv
10 Sep 20
IPO registration
5:26pm
S-1
h4pbofwb6jf1y fp
10 Sep 20
IPO registration
5:26pm
DRS
EX-10.7
k90v8o
6 Aug 20
Draft registration statement
12:00am
DRS
EX-10.6
52xyd
6 Aug 20
Draft registration statement
12:00am
DRS
6gyauze0
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next